MENU
NNCSF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Nanosonics (NNCSF) Ownership - Who owns Nanosonics?

Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures... Show more

Profile

Industry
N/A
Address
7-11 Talavera Road
Phone
+61 280631600
Employees
482
Web
https://www.nanosonics.com.au

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
835.86M
P/E Ratio
60.67
Total Cash
161.29M
Projected Growth
N/A
Total Debt
7.69M
Revenue
198.93M
Risk (Beta)
0.27
Dividend Yield
N/A
Total Cash/Share
0.53
Total Debt/Equity
N/A
Revenue/Share
0.43 USD as % of share price

Fundamentals

NNCSF
Capitalization
836M
P/E Ratio
60.67
Risk (Beta)
0.27
Dividend Yield
N/A
Total Cash
161M
Total Cash/Share
0.53
Total Debt
7.69M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.43%
Revenue
199M
ROE
N/A
Book Value
210M
P/B Ratio
5.87
Cash Flow
N/A
Earnings
0.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
115M
Current Ratio
5.66
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
31.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
8.11
Shares Held By Institutions
291M
Shares Outstanding - Current
304M
Total Liabilities
62.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
28.571
View a ticker or compare two or three
NNCSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
7-11 Talavera Road
Phone
+61 280631600
Employees
482
Web
https://www.nanosonics.com.au